Quality problems at a Lincoln, Nebraska, pharmaceuticals manufacturing plant has led to the recall of a number of over-the-counter medications sold by Novartis Consumer Health. While the company says no injuries have been reported at this time, the recall was issued in an attempt to minimize harm from a medication error. The medications affected by the recall are:
- Gas-X Prevention
Problems at the manufacturing plant resulted in tablets, capsules and caplets of medications being mixed together and sold in the same bottle, as well as broken and chipped tablets being bottled instead of discarded.
Novartis recalled the products to prevent consumers from taking the wrong medication, with the possibility of an allergic reaction, or getting too much or too little of a certain medication.
Manufacturing defects of medications and medical products can result in personal injury claims and even class action lawsuits. Recalling products as soon as an error is discovered is the most responsible course of action, although it does not prevent the drug manufacturer from being held liable for injuries that may already have been caused by the medication error.
Source: Pioneer Press, "Novartis recalls Excedrin, NoDoz, Bufferin, Gas-X Prevention over reports of plant malfunction," from the Dow Jones Newswire, January 9, 2012.